Mabel Fernandes Figueiró

Mabel Fernandes Figueiró

Auto-generated profile, based on publicly available information

Mabel Fernandes Figueiró

HCOR

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 July 2024 in European Journal of Nutrition
Verified
Journal Article
Closed access
PDF file
ÂBÂngela Bersch-Ferreira
Ângela Bersch-Ferreira
ESElana Stein
Elana Stein
GWGustavo Waclawovsky
Gustavo Waclawovsky
LSLucas R. da Silva
Lucas R. da Silva
RMRachel Helena Vieira Machado
Rachel Helena Vieira Machado
AMAline Marcadenti
Aline Marcadenti

23 May 2024 in Nutrition Reviews
Verified
Journal Article
Closed access
PDF file
ÂBÂngela Bersch-Ferreira
Ângela Bersch-Ferreira
CWCamila Weschenfelder
Camila Weschenfelder
GWGustavo Waclawovsky
Gustavo Waclawovsky
LSLucas R da Silva
Lucas R da Silva
ESElana Stein
Elana Stein
AMAline Marcadenti
Aline Marcadenti
Nut-enriched diets have a positive impact on cardiovascular risk factors, such as body mass, blood pressure, and fasting blood glucose. However, studies in individuals undergoing secondary cardiovascular prevention show controversial results. This systematic review with meta-analysis assessed the effect of nut supplementation on anthropometric, glycemic, and blood pressure indices in patients with atherosclerotic cardiovascular disease, as well as the frequency of adverse events. Six databases were used for the search—PubMed, Cochrane Library, EMBASE, BVS (Biblioteca Virtual da Saude), Web of Science, and ClinicalTrials.gov—until February 2023, with no language restrictions. The Cochrane Handbook for Systematic Reviews of Interventions methodology and the PICOS (Population, Intervention, Comparison, Outcome, Setting/design) strategy were used. Seven independent reviewers were involved in data extraction and resolution of disagreements. Certainty of the evidence was evaluated using the GRADE (Grading of Recommendations Assessment, Development and Evaluation) system. From 5187 records identified, 6 publications containing data referring to 5 randomized clinical trials (n = 436) were included in the final analyses. The nuts evaluated were almonds, pecans, Brazil nuts, and mixed nuts, with portions that varied between 5 g and 85 g (median: 30 g/day). The intervention period varied between 6 and 12 weeks. The nuts had no effect on fasting glucose and anthropometric indices, although the certainty of the evidence for most of these outcomes was low or very low. They also had no effect on systolic (mean difference [MD]: -1.16 mmHg [95% CI, -5.68 to 3.35], I2 = 0%—moderate certainty of evidence) or diastolic (MD: 0.10 mmHg [95% CI, -2.30 to 2.51], I2 = 0%—high certainty of evidence) blood pressure. It was not possible to aggregate data on adverse events. Nut supplementation had no effect on blood pressure, fasting glucose, or anthropometric profile in the context of atherosclerotic cardiovascular disease. PROSPERO registration no. CRD42020163456.

10 December 2025 in Nutrition Reviews
Verified
Journal Article
Closed access
ESElana Stein
Elana Stein
GDGraziela Biude Silva Duarte
Graziela Biude Silva Duarte
ÂBÂngela Bersch-Ferreira
Ângela Bersch-Ferreira
CWCamila Weschenfelder
Camila Weschenfelder
MFMabel F Figueiro
Mabel F Figueiro
AMAline Marcadenti
Aline Marcadenti
Coronary artery disease (CAD) remains the leading cause of death worldwide and has a multifactorial etiology involving genetic, metabolic, and behavioral factors. Hypertension and dyslipidemia contribute significantly to atherosclerosis progression, and these conditions may be influenced by microRNAs (miRNAs), which act as post-transcriptional gene expression regulators. In turn, miRNA expression can be modulated by nutrient-dense dietary patterns or cardioprotective foods, such as nuts. Despite growing interest in miRNAs and cardiovascular disease (CVD) risk, few reviews have specifically addressed the unique role of nuts in modulating miRNA expression, particularly regarding gaps in secondary prevention of CAD. This study summarizes the main miRNAs associated with blood pressure, lipid metabolism, and atherosclerotic disease, as well as the current evidence on how nut consumption influences their expression. Several miRNAs, including miR-1, miR-21, the miR-29 family, miR-30a/b, miR-133, miR-143, miR-145, and miR-221/222, are dysregulated in hypertension and associated with circadian blood pressure patterns, left ventricular hypertrophy, and antihypertensive response. Others, such as miR-122, miR-33a/b, miR-148a, miR-483-5p, and miR-145, are linked to lipid metabolism, plaque instability, and ischemic outcomes. Nut-rich diets, particularly the Mediterranean diet, seem to modulate miRNAs associated with pathways involved in lipid homeostasis, endothelial function, and inflammation. Data from clinical trials conducted in primary CVD prevention setting have shown changes in circulating miRNAs in response to diets rich in nuts. Additional studies with Brazil nuts, pistachios, almonds, and walnuts supplementation also reported modulation of miRNAs involved in lipid homeostasis, inflammation, and insulin resistance, including significant changes in expression of miR-15a, miR-21, miR-328, miR-454-3p, miR-29a-3p, miR-192, miR-330-3p, miR-32-5p, miR-29b-3p, and miR-551a. Nonetheless, it appears no studies have yet evaluated the effect of nut supplementation on miRNAs in secondary prevention of CAD. Although the evidence is promising, more research is needed to clarify the impact of nut consumption on miRNA modulation, particularly in secondary prevention of CVD.

5 August 2024 in International Journal of Cardiovascular Sciences
Verified
Journal Article
Open access
PDF file
LULiza Yurie Teruya Uchimura
Liza Yurie Teruya Uchimura
COCintia de Freitas Oliveira
Cintia de Freitas Oliveira
MFMabel Fernandes Figueiró
Mabel Fernandes Figueiró
CTCamila Pereira Pinto Toth
Camila Pereira Pinto Toth
CLCamila Roncon de Lima
Camila Roncon de Lima
PVPatricia Vendramim
Patricia Vendramim
Introduction Cardiovascular diseases (CVD) are a major cause of mortality in Brazil, requiring the improvement of healthcare mechanisms that can promote rapid and effective care for patients. Objectives To identify and characterize Brazilian policies and programs (PP) regarding urgency and emergency care in the context of CVD. Method The scoping review followed recommendations from the Joanna Briggs Institute (JBI). The search for studies was conducted across seven databases. The screening and eligibility steps were performed by reviewers independently, with [...] Abstract Introduction Cardiovascular diseases (CVD) are a major cause of mortality in Brazil, requiring the improvement of healthcare mechanisms that can promote rapid and effective care for patients. Objectives To identify and characterize Brazilian policies and programs (PP) regarding urgency and emergency care in the context of CVD. Method The scoping review followed recommendations from the Joanna Briggs Institute (JBI). The search for studies was conducted across seven databases. The screening and eligibility steps were performed by reviewers independently, with

1 January 2024 in Epidemiologia e Serviços de Saúde
Verified
Journal Article
Open access
PDF file
LULiza Yurie Teruya Uchimura
Liza Yurie Teruya Uchimura
TYTatiana Yonekura
Tatiana Yonekura
MFMabel Fernandes Figueiró
Mabel Fernandes Figueiró
JQJeane Roza Quintans
Jeane Roza Quintans
PFPatrícia Freire
Patrícia Freire
FMFernando Henrique de Albuquerque Maia
Fernando Henrique de Albuquerque Maia
Objetivo Identificar as evidências disponíveis sobre o risco de desenvolver câncer em pessoas transgênero que se tratam por meio de hormonioterapia.

14 August 2026 in Health Research Policy and Systems
Verified
Journal Article
Open access
PDF file
MSMaria Sharmila Alina de Sousa
Maria Sharmila Alina de Sousa
FFFabiana Raynal Floriano
Fabiana Raynal Floriano
MFMabel Fernandes Figueiró
Mabel Fernandes Figueiró
ASAndrea Brigida de Souza
Andrea Brigida de Souza
EBEdison Bicudo
Edison Bicudo
VSVania Cristina Canuto Santos
Vania Cristina Canuto Santos
Brazil’s National Committee for Health Technology Incorporation (Conitec) has progressively expanded mechanisms for public and patient participation